ACC, M., ACR, D., LL, F., AB, B., CR, d. L., E, P., & EB, d. A. (2021). Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence. Bioorganic & medicinal chemistry, 33, 115996. https://doi.org/10.1016/j.bmc.2021.115996
Chicago Style (17th ed.) CitationACC, Miranda, Durante ACR, Fuscaldi LL, Barbezan AB, de Lima CR, Perini E, and de Araújo EB. "Anti-HER2 Monoclonal Antibody Based-radioimmunoconjugates: Assessment of the Chelating Agent Influence." Bioorganic & Medicinal Chemistry 33 (2021): 115996. https://doi.org/10.1016/j.bmc.2021.115996.
MLA (9th ed.) CitationACC, Miranda, et al. "Anti-HER2 Monoclonal Antibody Based-radioimmunoconjugates: Assessment of the Chelating Agent Influence." Bioorganic & Medicinal Chemistry, vol. 33, 2021, p. 115996, https://doi.org/10.1016/j.bmc.2021.115996.